Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMc Mining Regulatory News (MCM)

Share Price Information for Mc Mining (MCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.00
Bid: 7.50
Ask: 8.50
Change: 0.00 (0.00%)
Spread: 1.00 (13.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 8.00
MCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Receipt of Notice of Intention to Make a Takeover

2 Nov 2023 13:15

RNS Number : 2322S
MC Mining Limited
02 November 2023
 

ANNOUNCEMENT 2 November 2023

 

RECEIPT OF NOTICE OF INTENTION TO MAKE A TAKEOVER - TAKE NO ACTION

MC Mining Limited (MCM or the Company) has received a letter dated 1 November 2023 (Proposal Letter) from Senosi Group Investment Holdings Proprietary Limited and Dendocept Proprietary Limited, each substantial shareholders of the Company, sent on behalf of shareholders and associates stated to represent in aggregate 64.5%[1] of the issued capital in the Company (together, the Consortium).

 

The Proposal Letter outlines the Consortium's proposal and intention to make an off-market cash takeover offer for all the shares in the Company not currently held by the Consortium (Proposed Takeover). The Proposal Letter also states that the Consortium has made an application to the Australian Securities & Investments Commission (ASIC) under section 655A(1) of the Corporations Act 2001 (Cth) (Act), seeking relief from section 606 of the Act to permit the Consortium to enter into a joint bidding agreement for the purposes of undertaking a joint takeover bid for the Company.

 

The Proposal Letter refers to the Consortium's earlier confidential and incomplete, non-binding, conditional and indicative offer dated 5 September 2023 from Senosi Group Investment Holdings Proprietary Limited and Dendocept Proprietary Limited (NBIO). The NBIO set out indicative but incomplete details of a proposed takeover by Senosi Group Investment Holdings Proprietary Limited and Dendocept Proprietary Limited, including an indicative cash consideration offer range of AUD$0.20-AUD$0.23 per ordinary share, based on the Company's undiluted share capital. The NBIO proposal was subject to a number of conditions, including third party and regulatory approvals. In its Proposal Letter, the Consortium has also stated that it is its ''present intention that it will be a condition of the bid that no convertible securities vest as a result of the bid''.

 

Following the receipt of the NBIO, the Company established an Independent Board Committee (IBC) to consider the NBIO on behalf of shareholders not associated with the Consortium and to seek to evaluate and improve the indicative offer price. The IBC members comprise Mr Khomotso Mosehla, Mr Nhlanhla Nene, Mr Andrew Mifflin and Mr Julian Hoskin, being the Company's directors other than Ms Yi (Christine) He and Mr Ontiretse Mathews Senosi, who are representatives of the Consortium. Other directors associated with the Consortium and not included in the IBC are Mr An Chee Sin and Mr Zhen Brian He. Mr Godfrey Gomwe, the Chief Executive Officer of the Company, is an invitee of the IBC.

 

The IBC has been evaluating the indicative terms of the NBIO, including taking advice from its financial and Australian and South African legal advisors. Adelaide Equity Advisors as Financial Advisor, K&L Gates as Australian Legal Advisor and each of Webber Wentzel and Falcon & Hume, as South African Legal Advisors have been engaged by the IBC.

Whilst the Consortium's Proposal Letter notifies the Company of an intention and proposal to make a takeover offer for the purposes of ASX Listing Rule 7.9[2], it does not yet provide a definitive offer price for the Proposed Takeover. The progress of the Proposed Takeover is also subject to the Consortium obtaining regulatory relief from ASIC.

 

Accordingly, the IBC advises shareholders to TAKE NO ACTION at this stage in relation to the Proposed Takeover, until they receive further guidance from the IBC. A further announcement will be made by the Company as and when more complete and definitive details are received.

 

Khomotso Mosehla

Chairman of the IBC

 

This announcement has been approved by the Company's Disclosure Committee.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended.

 

 

For more information contact:

 

 

Tony Bevan

Company Secretary

Endeavour Corporate Services

+61 8 9316 9100

 

Company advisors:

 

Richard Johnson / Rob Patrick

Nominated Adviser

Strand Hanson Limited

+44 20 7409 3494

 

Rory Scott

 

Broker (AIM)

Tennyson Securities

+44 20 7186 9031

 

Marion Brower

Financial PR (South Africa)

R&A Strategic Communications

+27 11 880 3924

 

BSM Sponsors Proprietary Limited is the nominated JSE Sponsor

 

About MC Mining Limited:

 

MC Mining is an AIM/ASX/JSE-listed coal exploration, development and mining company operating in South Africa. MC Mining's key projects include the Uitkomst Colliery (steelmaking and thermal coal), Makhado Project (steelmaking hard coking coal), Vele Colliery (steelmaking semi-soft coking and thermal coal), and the Greater Soutpansberg Projects (steelmaking coking and thermal coal).

 

 


[1] As at the date of this announcement, Senosi Group Investment Holdings (Pty) Limited holds 23.4% and Dendocept Proprietary Limited holds 6.9% of the current issued capital of the Company.

[2] This rule places a three month restriction on a target takeover entity from issuing equity securities without shareholder approval, subject to certain exceptions.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBDBDBDUGDGXD
Date   Source Headline
31st Oct 20232:30 pmRNSDespatch of Annual Report and Notice of AGM
31st Oct 20239:25 amRNSActivities Report for the Quarter Ended 30 Sep 23
31st Oct 20239:25 amRNSAppendix 5B
27th Oct 202310:30 amRNSIssue of Equity
5th Oct 202310:30 amRNSAnnual General Meeting Details
21st Sep 202312:13 pmRNSResults for the Full Year Ended 30 June 2023
15th Sep 202310:10 amRNSChange of Australian Share Registry Address
31st Jul 20239:35 amRNSAppendix 5B
31st Jul 20239:33 amRNSACTIVITIES REPORT FOR QUARTER ENDED 30 JUNE 2023
25th Jul 20237:45 amRNSIDC Extension Announcement
30th Jun 202312:15 pmRNSTrading Update
28th Apr 20239:35 amRNSAppendix 5B
28th Apr 20239:30 amRNSActivities Report for the Quarter Ended 31 Mar 23
27th Apr 20239:00 amRNSHolding(s) in Company
26th Apr 202311:20 amRNSMakhado Project Update
31st Mar 20238:02 amRNSIssue of Shares Under the Performance Rights Plan
16th Mar 20237:00 amRNSChange of JSE Sponsor
15th Mar 20237:40 amRNSInterim Financial Report
15th Mar 20237:40 amRNSHalf-year Results
10th Mar 20231:00 pmRNSDirector Appointments & Resignation
22nd Feb 20232:05 pmRNSSecond Price Monitoring Extn
22nd Feb 20232:00 pmRNSPrice Monitoring Extension
31st Jan 20237:31 amRNSAppendix 5B
31st Jan 20237:30 amRNSActivities Report for the Quarter Ended 31 Dec 22
19th Jan 20232:15 pmRNSGrant of Options & Performance Rights to Directors
23rd Dec 20228:37 amRNSOutsourcing of the Vele Aluwani Colliery
20th Dec 20223:00 pmRNSExtension of Coal Sales & Marketing Agreement
1st Dec 20229:00 amRNSIDC Loan Update
30th Nov 20224:32 pmRNSResult of AGM
11th Nov 20226:20 pmRNSDirectors' Dealings
4th Nov 20222:06 pmRNSSecond Price Monitoring Extn
4th Nov 20222:00 pmRNSPrice Monitoring Extension
4th Nov 202210:00 amRNSFully Underwritten Rights Issue Offer Closes
31st Oct 20229:31 amRNSAppendix 5B
31st Oct 20229:30 amRNSActivities Report for the Quarter Ended 30 Sep 22
31st Oct 20227:00 amRNSDespatch of Annual Report and Notice of AGM
7th Oct 202211:07 amRNSAnnual General Meeting Details
30th Sep 20229:45 amRNSResults for the Full Year Ended 30 June 2022
28th Sep 20222:05 pmRNSSecond Price Monitoring Extn
28th Sep 20222:00 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSFully Underwritten A$40M Rights Issue
23rd Sep 20222:06 pmRNSSecond Price Monitoring Extn
23rd Sep 20222:00 pmRNSPrice Monitoring Extension
12th Sep 202211:05 amRNSSecond Price Monitoring Extn
12th Sep 202211:00 amRNSPrice Monitoring Extension
9th Sep 202211:29 amRNSLifting of ASX Trading Halt
8th Sep 20223:59 pmRNSExtension of the Cautionary Announcement
8th Sep 202211:21 amRNSTrading Halt on the ASX
30th Aug 202210:00 amRNSMakhado, Vele and GSP Updates
29th Jul 202210:01 amRNSAppendix 5B

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.